Abstract
This study was conducted to evaluate the effect of sinapic acid, a cinnamic acid derivative, on inflammatory changes in a mouse model of colitis. Colitis was induced by intracolonic instillation of 2,4,6-trinitrobenzenesulfonic acid (TNBS). Sinapic acid (10, 30, and 100 mg/kg) and dexamethasone (2 mg/kg) were orally administered to Balb/c female mice after TNBS instillation. The anti-inflammatory effect of sinapic acid on colonic injury or damage was assessed by clinical, macroscopic, microscopic, and biochemical analyses. Compared with TNBS control, treatment with sinapic acid significantly improved colonic weight and length and decreased the macroscopic and microscopic changes in TNBS-induced colitis. Furthermore, myeloperoxidase activity and the colonic tissue levels of malondialdehyde and tumor necrosis factor alpha were decreased by administration of sinapic acid. The findings of this study suggest that sinapic acid exerts anti-inflammatory effects on intestinal inflammation and can be selected as a novel therapeutic candidate in the treatment of inflammatory bowel disease.
Similar content being viewed by others
References
Chachu KA, Osterman MT (2016) How to diagnose and treat IBD mimics in the refractory IBD patient who does not have IBD. Inflamm Bowel Dis 22:1262–1274
Chen C (2016) Sinapic acid and its derivates as medicine in oxidative stress-induced diseases and aging. Oxid Med Cell Longev. https://doi.org/10.1155/2016/3571614
Cuvelier ME, Richard H, Berset C (1992) Comparison of the antioxidative activity of some acid-phenols—structure–activity relationship. Biosci Biotechnol Biochem 56:324–325
Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolae DL, Cho JH (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461–1463
Duvnjak M, Bilic A, Barsic N, Tomasic V, Stojsavljevic S (2013) Classical medications in the treatment of inflammatory bowel diseases. Acta Med Croatica 67:11–124
Fukuda W, Takagi T, Katada K, Mizushima K, Okayama T, Yoshida N, Kamada K, Uchiyama K, Ishikawa T, Handa O, Konishi H, Yagi N, Ichikawa H, Yoshikawa T, Cepinskas G, Naito Y, Itoh Y (2014) Anti-inflammatory effects of carbon monoxide-releasing molecule on trinitrobenzene sulfonic acid-induced colitis in mice. Dig Dis Sci 59:1142–1151
Galano A, Francisco-Marquez M, Alvarez-Idaboy JR (2011) Mechanism and kinetics studies on the antioxidant activity of sinapinic acid. Phys Chem Chem Phys 13:11199–11205
Gan XL, Hei ZQ, Huang HQ, Chen LX, Li SR, Cai J (2006) Effect of Astragalus membranaceus injection on the activity of the intestinal mucosal mast cells after hemorrhagic shock-reperfusion in rats. Chin Med J (Engl) 119:1892–1898
Hooper KM, Barlow PG, Stevens C, Henderson P (2017) Inflammatory bowel disease drugs: a focus on autophagy. J Crohns Colitis 11:118–127
Jia Y, Guan Q, Jiang Y, Salh B, Guo Y, Tu P, Du C (2014) Amelioration of dextran sulphate sodium-induced colitis in mice by echinacoside-enriched extract of Cistanche tubulosa. Phytother Res 28:110–119
Katz LH, Kopylov U, Fudim E, Yavzori M, Picard O, Ungar B, Eliakim R, Ben-Horin S, Chowers Y (2014) Expression of IL-2, IL-17 and TNF-alpha in patients with Crohn’s disease treated with anti-TNF antibodies. Clin Res Hepatol Gastroenterol 38:491–498
Kim DH, Yoon BH, Jung WY, Kim JM, Park SJ, Park DH, Huh Y, Park C, Cheong JH, Lee KT, Shin CY, Ryu JH (2010) Sinapic acid attenuates kainic acid-induced hippocampal neuronal damage in mice. Neuropharmacology 59:20–30
Liu X, Wang J (2011) Anti-inflammatory effects of iridoid glycosides fraction of Folium syringae leaves on TNBS-induced colitis in rats. J Ethnopharmacol 133:780–787
Luceri C, Guglielmi F, Lodovici M, Giannini L, Messerini L, Dolara P (2004) Plant phenolic 4-coumaric acid protects against intestinal inflammation in rats. Scand J Gastroenterol 39:1128–1133
Menchen LA, Colon AL, Moro MA, Leza JC, Lizasoain I, Menchen P, Alvarez E, Lorenzo P (2001) N-(3-(aminomethyl)benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, decreases colonic inflammation induced by trinitrobenzene sulphonic acid in rats. Life Sci 69:479–491
Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96:795–803
Niwa T, Doi U, Kato Y, Osawa T (1999) Inhibitory mechanism of sinapinic acid against peroxynitrite-mediated tyrosine nitration of protein in vitro. FEBS Lett 459:43–46
Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358
Park SY, Neupane GP, Lee SO, Lee JS, Kim MY, Kim SY, Park YJ, Kim JA (2014) Protective effects of Pogostemon cabin Bentham water extraction on inflammatory cytokine expression in TNBS-induced colitis in rats. Arch Pharm Res 37:253–262
Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347:417–429
Sadar SS, Vyawahare NS, Bodhankar SL (2016) Ferulic acid ameliorates TNBS-induced ulcerative colitis through modulation of cytokines, oxidative stress, iNOS, COX-2, and apoptosis in laboratory rats. EXCLI J 15:482–499
Sartor RB, Cromartie WJ, Powell DW, Schwab JH (1985) Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments. Gastroenterology 89:587–595
Van Meeteren ME, Meijssen MA, Zijlstra FJ (2000) The effect of dexamethasone treatment on murine colitis. Scand J Gastroenterol 35:517–521
Vetuschi A, Latella G, Sferra R, Caprilli R, Gaudio E (2002) Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci 47:1447–1457
Wallace JL (1988) Release of platelet-activating factor (PAF) and accelerated healing induced by a PAF antagonist in an animal model of chronic colitis. Can J Physiol Pharmacol 66:422–425
Wang YH, Dong J, Zhang JX, Zhai J, Ge B (2016) Effects of mimic of manganese superoxide dismutase on 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats. Arch Pharm Res 39:1296–1306
Zaotrski H, Sałaga M, Zielińska M, Piechota-Polańczyk A, Owczarek K, Kordek R, Lewandowska U, Chen C, Fichna J (2015) Experimental colitis in mice is attenuated by topical administration of chlorogenic acid. Naunyn Schmiedebergs Arch Pharmacol 388:643–651
Zhang Z, Wu X, Cao S, Wang L, Wang D, Yang H, Feng Y, Wang S, Li L (2016) Caffeic acid ameliorates colitis in association with increased Akkermansia population in the gut microbiota of mice. Oncotarget 7:31790–31799
Zou Y, Dai SX, Chi HG, Li T, He ZW, Wang J, Ye CG, Huang GL, Zhao B, Li WY, Wan Z, Feng JS, Zheng XB (2015) Baicalin attenuates TNBS-induced colitis in rats by modulating the Th1/Treg paradigm. Arch Pharm Res 38:1873–1887
Acknowledgements
This research was supported by the Chung-Ang University Research Grants in 2015.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares no conflict of interest.
Rights and permissions
About this article
Cite this article
Lee, JY. Anti-inflammatory effects of sinapic acid on 2,4,6-trinitrobenzenesulfonic acid-induced colitis in mice. Arch. Pharm. Res. 41, 243–250 (2018). https://doi.org/10.1007/s12272-018-1006-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-018-1006-6